Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
dacarbazine (DTIC) Triazines (Three Attached Nitrogen Atoms) Alkylating Agents
DCIS
dCTP
deep venous thrombosis (DVT)
dehydrogenase (DPD)
deoxycytidine kinase (DCK)
deoxynucleotide triphosphates (dNTPs) Answer 3.7 Ribonucleotide Reductase (RNR) is Responsible for Synthesizing Deoxyribonucleotides
deoxythymidine monophosphate (dTMP) Folic Acid Cycle as Relevant for Conversion of Deoxyuridine Monophosphate (dUMP) Pyrimidine Analogs Mechanism of Leucovorin (LV) "Rescue" in High-Dose Methotrexate (MTX)
DFHR
DHEA
DHT
differentiation syndrome (DS) Differentiating Agents and Microenvironment Answer 8.2 Question 8.2
diffuse, large B cell lymphoma (DLBCL)
dihydrofolate reductase (DFHR) Answer 3.7 Question 4.5 Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase
disease-free survival (DFS) Answer 16.5 Basic Drug Development With Structural Considerations
DLBCL
DNA damage response (DRR) DNA-PK targeting PARP inhibitors DNA Repair, Apoptotic Pathways, CDK Inhibitors
DNA repair overview risk and intensity
DNA structure
dNTPs
dose-escalation limiting toxicity (DLT)
DPD
DRR
Drug approval and regulatory issues dose refinement studies food effect INDâchr(128)”enabling nonclinical studies for cancer drugs additional pharmacology considerations drug-drug interaction hepatic impairment QT prolongation renal impairment recommended phase 2 dose (RP2D)
DAMPA
DCK
DDB1
dehydroepiand rosterone (DHEA)
de novo synthesis of thymidine monophosphate (dTMP)
deoxycytidine triphosphate (dCTP)